Treeline Bio emerges from the shadows with $1B+ raised

Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences' well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date.

Editor's Pick

Top Story Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences' well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date. Sponsored The Role of RWD in Revolutionizing Clinical Trial Design Presented by PurpleLab Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people. Learn more We Want Your Feedback Your voice helps shape the stories, insights, and events we deliver. Take just a few minutes to complete our short, anonymous audience survey and let us know what you enjoy and what you'd like to see more of. As a thank you, you'll be entered for a chance to win a $250 Amazon gift card. Take the Survey

Featured News

Exploring The Next Generation of Healthcare Benefits [Sponsored] In this webinar, sponsored by Solera Health, executives will share how companies can make the most of healthcare benefits. NewDays Secures $7M To Expand Treatment for Cognitive Impairment, Dementia NewDays' $7 million seed round was led by General Catalyst and Madrona. The funds will be used to expand into additional states and grow its team. What One Investor Believes Is the Key to Healthcare AI Success Chirag Shah, partner at Define Ventures, thinks the success of a healthcare AI startup often depends on its ability to move beyond a narrow point solution. By integrating AI into workflows and expanding from initial "wedges" into full platforms, startups can stand out from the competition, he said. Caught Between Visits: How Our System Fails People With Parkinson's and Dementia Much of today's care infrastructure was built for a different era, when medicine focused on acute illnesses and short-term fixes. But neurodegenerative diseases don't follow that script, and neither can we. We have the tools to build something better: care that stays with people, adapts to their needs, and helps them live not just longer, but better. Easing Frontline Pressure: How AI Can Lift the Administrative Burden Off Care Teams AI agents excel in operating within compliance frameworks, offloading structured tasks while escalating edge cases to human providers. They show great promise in helping reclaim clinical capacity and reduce the mounting administration associated with modern medicine.

Video   California's efforts to rein in PBMs On Debunked, Paul Markovich, president and CEO of Ascendiun, discussed a proposed California bill that would delink PBM compensation from drug list prices. He cited a recent Health Affairs study that found the change could generate nearly $100 billion in savings.

Sponsored The Top-Rated Suppliers of Lu-177 for Cancer Research Presented by SHINE Technologies With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. Learn More.

Resources

sponsored 5 Top-Rated Electronic Medical Records Software for SMBs This report can help small and midsize businesses compare the five top-rated EMR software solutions. Read More

MedCity News • PO Box 901 • New York, NY unsubscribe